Ming-Chang Hsieh Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

3/2022

The Establishment of a Noninvasive Bioluminescence-Specific Viral Encephalitis Model by Pseudorabies Virus-Infected NF-κBp-Luciferase Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Chang Hsieh Research Topics

Disease

10	Neoplasms (Cancer) 03/2022 - 01/2013
5	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 05/2014
3	Mouth Neoplasms (Oral Cancer) 06/2020 - 01/2020
2	Liver Neoplasms (Liver Cancer) 03/2022 - 04/2016
2	Infections 03/2022 - 04/2013
2	Inflammation (Inflammations) 03/2022 - 01/2021
2	Nasopharyngeal Carcinoma 08/2021 - 01/2021
2	COVID-19 01/2021 - 01/2021
1	Viral Encephalitis 03/2022
1	Encephalitis (Encephalitis, Rasmussen) 03/2022
1	Neuroinflammatory Diseases 03/2022
1	Leukemia 11/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2020
1	Squamous Cell Carcinoma of Head and Neck 05/2020
1	Neuroblastoma 01/2020
1	Papillomavirus Infections 11/2018
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 12/2017
1	Fibrosis (Cirrhosis) 05/2014
1	Virus Diseases (Viral Diseases) 04/2013
1	Nephritis 04/2013
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2013
1	Glomerulonephritis 01/2013
1	Brain Neoplasms (Brain Tumor) 01/2013

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 11/2020 - 01/2019
2	AlkaloidsIBA 03/2022 - 08/2021
2	CaspasesIBA 03/2022 - 06/2020
2	dehydrocrenatidineIBA 03/2022 - 08/2021
2	Antineoplastic Agents (Antineoplastics)IBA 03/2022 - 06/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
2	p38 Mitogen-Activated Protein KinasesIBA 12/2017 - 04/2016
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2017 - 01/2016
1	Death Domain ReceptorsIBA 03/2022
1	Interleukin-6 (Interleukin 6)IBA 03/2022
1	Biomarkers (Surrogate Marker)IBA 03/2022
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2022
1	InterleukinsIBA 03/2022
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2022
1	LuciferasesIBA 03/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022
1	CytokinesIBA 03/2022
1	Indicators and Reagents (Reagents)IBA 08/2021
1	pinosylvinIBA 01/2021
1	butylidenephthalideIBA 01/2021
1	LuteolinIBA 01/2021
1	Chlorogenic AcidIBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	tocilizumab (atlizumab)FDA Link 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 06/2020
1	Sesame Oil (Oil, Sesame)IBA 05/2020
1	Matrix Metalloproteinases (MMPs)IBA 05/2020
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 05/2020
1	LigninIBA 05/2020
1	sesaminIBA 05/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 11/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2017
1	coronarin DIBA 12/2017
1	glabridinIBA 04/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Vascular Endothelial Growth Factor CIBA 05/2014
1	CreatinineIBA 04/2013
1	Methanol (Carbinol)IBA 01/2013

Therapy/Procedure

3	Therapeutics 01/2021 - 04/2016
2	Drug Therapy (Chemotherapy) 11/2020 - 01/2013
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020 - 01/2013
1	Renal Dialysis (Hemodialysis) 04/2013
1	Transplantation 04/2013
1	Peritoneal Dialysis 04/2013
1	Kidney Transplantation 04/2013